Adirondack Trust Company’s Anixa Biosciences ANIX Stock Holding History

Adirondack Trust Company’s Portfolio ANIX Stock Details ANIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,000	Closed	-$22.8K	–	498
2023 Q3	$22.8K	Hold	7,000	–	–	0.01%	275
2023 Q2	$25.1K	Hold	7,000	–	–	0.01%	251
2023 Q1	$30K	Hold	7,000	–	–	0.02%	236
2022 Q4	$29.8K	Hold	7,000	–	–	0.02%	235
2022 Q3	$34K	Hold	7,000	–	–	0.02%	223
2022 Q2	$21K	Hold	7,000	–	–	0.01%	243
2022 Q1	$19K	Hold	7,000	–	–	0.01%	255
2021 Q4	$21K	Hold	7,000	–	–	0.01%	246
2021 Q3	$33K	Buy	+7,000	New	+$31.6K	0.02%	213

Other funds holding ANIX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MWM

Mission Wealth Management Santa Barbara, California $4.86B AUM 22.78% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Adirondack Trust Company's ANIX Position: Q4 2023 in Review

Adirondack Trust Company sold out of Anixa Biosciences (ANIX) in Q4 2023, closing a stake of 7,000 shares — an estimated $22.8K sold.

Adirondack Trust Company first reported a position in ANIX in Q3 2021 and held it in 9 quarters. The position peaked at $34K in Q3 2022. 55 funds tracked by Wall St. Rank hold ANIX as of Q4 2023.

Adirondack Trust Company reported no remaining Anixa Biosciences position as of Q4 2023 after selling out during the quarter.
Adirondack Trust Company sold 7,000 Anixa Biosciences shares in Q4 2023, an estimated $22.8K.
Adirondack Trust Company first reported a position in Anixa Biosciences in Q3 2021 and held it in 9 quarters.
Adirondack Trust Company's Anixa Biosciences position peaked at $34K in Q3 2022.
55 funds tracked by Wall St. Rank held Anixa Biosciences as of Q4 2023.

Based on Adirondack Trust Company's 13F filing for Q4 2023, filed 29 Mar 2024.